PIERIS PHARMACEUTICALS, INC.

Profile

Company Names

PIERIS PHARMACEUTICALS, INC.

Addresses

255 STATE STREET, 9TH FLOOR, BOSTON, MA 02109

255 STATE STREET, 9TH FLOOR, BOSTON, MA 02109

30 LISE-MEITNER-STRASSE, FREISING-WEIHENSTEPHAN, 2M 85354

Phone Numbers

857-246-8998
857 246 8998
4.90816E+13

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

NEVADA

Total Amount Raised:

$88,503,548.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-11-06 
$32,003,108.00 
$32,003,108.00 
$0.00 
Equity 
2
2016-06-02 
$16,500,440.00 
$16,500,440.00 
$0.00 
Equity 
1
2014-12-17 
$40,000,000.00 
$40,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANN 
 
BARBIER, M.D., PH.D. 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.
JEAN-PIERRE 
 
BIZZARI 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.   |  COMPUGEN LTD   |  APREA THERAPEUTICS, INC.
JEAN-PIERRE 
 
BIZZARI, M.D. 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.
TOM 
 
BURES 
EXECUTIVE OFFICER
PIERIS PHARMACEUTICALS, INC.
DARLENE 
 
DEPTULA-HICKS 
EXECUTIVE OFFICER
ICAD INC   |  PIERIS PHARMACEUTICALS, INC.   |  NORTHERN MOSAIC LP   |  AERAMI THERAPEUTICS HOLDINGS, INC.   |  ABCURO, INC.   |  NORMUNITY HOLDING COMPANY, LLC
DARLENE 
M. 
DEPTULA-HICKS 
EXECUTIVE OFFICER
PIERIS PHARMACEUTICALS, INC.
JAMES 
 
GERAGHTY 
DIRECTOR
VOYAGER THERAPEUTICS, INC.   |  IMMUNEXCITE, INC.   |  FULCRUM THERAPEUTICS, INC.   |  PIERIS PHARMACEUTICALS, INC.
HITTO 
 
KAUFMANN, PH.D. 
EXECUTIVE OFFICER
PIERIS PHARMACEUTICALS, INC.
CHAU 
 
KHUONG 
DIRECTOR
CERAPEDICS INC   |  AERPIO THERAPEUTICS, INC.   |  INSPIRE MEDICAL SYSTEMS, INC.   |  PIERIS PHARMACEUTICALS, INC.   |  SYNLOGIC, LLC   |  AERPIO PHARMACEUTICALS, INC.   |  SYNLOGIC, INC.   |  SYNLOGIC, INC.   |  PERFUSE THERAPEUTICS, INC.   |  GRAYBUG VISION, INC.   |  NOCTRIX HEALTH, INC.   |  GENNAO BIO, INC.   |  RESTORA MEDICAL, INC.
PETER 
 
KIENER, D.PHIL. 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.
CHRISTOPHER 
 
KIRITSY 
DIRECTOR
AVAXIA BIOLOGICS, INC   |  ARISAPH PHARMACEUTICALS INC   |  PIERIS PHARMACEUTICALS, INC.   |  HTG MOLECULAR DIAGNOSTICS, INC
AHMED 
 
MOUSA 
EXECUTIVE OFFICER
PIERIS PHARMACEUTICALS, INC.
STEVEN 
 
PRELACK 
DIRECTOR
BIOVEX GROUP, INC.   |  PIERIS PHARMACEUTICALS, INC.   |  AERPIO PHARMACEUTICALS, INC.
MICHAEL 
 
RICHMAN 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.   |  NEXTCURE, INC.   |  CAPITAL INTEGRATION SYSTEMS LLC
MAYA 
R. 
SAID, SC.D. 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.
MATTHEW 
L. 
SHERMAN, M.D. 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.
CHRISTINA 
 
TAKKE 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.
STEPHEN 
S. 
YODER 
EXECUTIVE OFFICER, DIRECTOR
PIERIS PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-11-20
D
Link
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2019-11-06 
2016-06-15
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2016-06-02 
2014-12-31
D
Link
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2014-12-17 
2014-12-31
D
Link
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2014-12-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
WILLIAM BLAIR + COMPANY
1252
NONE
NONE
COWEN AND COMPANY, LLC
NONE
NONE
NONE
OPPENHEIMER + CO. INC.
NONE
NONE
NONE
TROUT CAPITAL LLC
NONE
TROUT CAPITAL LLC
131589
NORTHLAND SECURITIES, INC.
NONE
AMERICAN PORTFOLIOS FINANCIAL SERVICES, INC.
18487
KATALYST SECURITIES LLC
112494
DINOSAUR SECURITIES, L.L.C.
104446
KATALYST SECURITIES LLC
112494